Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 23 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 11370765

    RIP1 inhibitory compounds and methods for making and using the same

    Rigel Pharmaceuticals, Inc. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  2. US 11370786

    GLS1 inhibitors for treating disease

    The Board of Regents of the University of Texas System · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  3. US 11370774

    Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  4. US 11370769

    TRPC5 inhibitors and methods of using same

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  5. US 11370798

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  6. US 11370764

    RIP1 inhibitory compounds and methods for making and using the same

    Rigel Pharmaceuticals, Inc. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  7. US 11364227

    Sphingosine kinase 2 inhibitor for treating coronavirus infection

    RedHill Biopharma Ltd. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  8. US 11364235

    Method for treating cancer using a BCL-2 inhibitor in conjunction with an alpha-emitting radioimmunotherapeutic

    Actinium Phamaceuticals, Inc. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  9. US 11364211

    Methods for selecting phosphatase selective and non-selective phosphatase inhibitors

    United Kingdom Research and Innovation · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  10. US 11364300

    C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors

    Revolution Medicines, Inc. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  11. US 11365189

    Heterocyclic inhibitors of tyrosine kinase

    The Board of Regents of the University of Texas System · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  12. US 11365195

    Atypical inhibitors of monoamine transporters; method of making; and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  13. US 11358932

    N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  14. US 11357759

    Composition including ADAM9 inhibitor and the use thereof

    China Medical University · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  15. US 11357817

    Immunoproteasome inhibitor

    The Regents of the University of California · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  16. US 11359246

    Treatment of obesity with G-protein coupled receptor 75 (GPR75) inhibitors

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  17. US 11358947

    Substituted 2-acylamino-cycloalkylthiophene-3-carboxylic acid arylamides as inhibitors of calcium-activated chloride channel TMEM16A

    The Regents of the University of California · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  18. US 11352360

    TGF-beta inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  19. US 11351161

    Use of CDK9 inhibitors to reduce cartilage degradation

    The Regents of the University of California · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  20. US 11352356

    Inhibitors of plasma kallikrein and uses thereof

    Takeda Pharmaceutical Company Limited · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  21. US 11345700

    Methods of preparing inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted May 31, 2022 · Expires May 26, 2042

    granted
  22. US 11344559

    PI3KGAMMA inhibitors

    The Regents of the University of California · Granted May 31, 2022 · Expires May 26, 2042

    granted
  23. US 11344605

    Therapeutic use of inhibitors of t cell activation or stimulation

    HUMANITAS MIRASOLE S.P.A. · Granted May 31, 2022 · Expires May 26, 2042

    granted
  24. US 11345678

    Benzopyrazole compound used as RHO kinase inhibitor

    Medshine Discovery Inc. · Granted May 31, 2022 · Expires May 26, 2042

    granted